Holen Sie sich die Stockscreener-App
112.28
1.02%
1.23
Schlusskurs vom Vortag:
$111.05
Offen:
$111.72
24-Stunden-Volumen:
55,711
Relative Volume:
0.04
Marktkapitalisierung:
$22.11B
Einnahmen:
$7.60B
Nettoeinkommen (Verlust:
$1.08B
KGV:
21.35
EPS:
5.26
Netto-Cashflow:
$1.26B
1W Leistung:
+1.05%
1M Leistung:
+6.43%
6M Leistung:
+0.73%
1J Leistung:
-8.33%
1-Tages-Spanne:
$111.72
$112.55
1-Wochen-Bereich:
$109.50
$113.84
52-Wochen-Spanne:
$100.67
$133.90
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Firmenname
Zimmer Biomet Holdings Inc
Sektor
Branche
Telefon
(574) 267-6131
Adresse
345 EAST MAIN STREET, WARSAW, IN
Vergleichen Sie ZBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
112.11 | 22.11B | 7.60B | 1.08B | 1.26B | 5.26 |
|
ABT
Abbott Laboratories
|
128.59 | 221.77B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.02 | 151.38B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
399.95 | 149.08B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
92.17 | 117.21B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
73.39 | 41.95B | 6.60B | 4.16B | 490.10M | 6.93 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-07-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-05-21 | Hochstufung | Argus | Hold → Buy |
| 2024-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
| 2023-08-28 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-05-03 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Hochstufung | Jefferies | Underperform → Hold |
| 2023-03-29 | Eingeleitet | UBS | Sell |
| 2023-03-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Underweight |
| 2022-10-12 | Eingeleitet | Jefferies | Underperform |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-04-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-02 | Fortgesetzt | BofA Securities | Underperform |
| 2022-03-02 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-02-08 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Bestätigt | Citigroup | Buy |
| 2022-02-08 | Bestätigt | Deutsche Bank | Hold |
| 2022-02-08 | Bestätigt | JMP Securities | Mkt Outperform |
| 2022-02-08 | Bestätigt | JP Morgan | Neutral |
| 2022-02-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Bestätigt | Stifel | Buy |
| 2022-02-08 | Bestätigt | Truist | Buy |
| 2022-02-08 | Bestätigt | UBS | Neutral |
| 2022-02-08 | Bestätigt | Wells Fargo | Underweight |
| 2022-02-02 | Herabstufung | UBS | Buy → Neutral |
| 2022-01-19 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Herabstufung | Needham | Strong Buy → Buy |
| 2021-12-07 | Eingeleitet | Loop Capital | Buy |
| 2021-11-23 | Herabstufung | Argus | Buy → Hold |
| 2021-09-14 | Fortgesetzt | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-04-09 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Bestätigt | Needham | Strong Buy |
| 2020-10-20 | Eingeleitet | Northland Capital | Market Perform |
| 2020-09-11 | Eingeleitet | Wolfe Research | Outperform |
| 2020-08-05 | Bestätigt | Needham | Strong Buy |
| 2020-04-28 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-09 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Bestätigt | Needham | Strong Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-07 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-09-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Hochstufung | Argus | Hold → Buy |
| 2019-07-30 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Hochstufung | Needham | Buy → Strong Buy |
Alle ansehen
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
Gries Financial LLC Purchases Shares of 8,196 Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Paragon 28 stock rating cut to Equal Weight by Stephens - MSN
Zimmer Biomet's SWOT analysis: stock outlook amid expansion and ERP challenges - Investing.com
Zimmer Biomet buying Paragon 28 for $1.1B to bolster F&A offerings - BioWorld Online
Zimmer Biomet reaches agreement to acquirement Colorado-based medical device company - Fort Wayne Journal Gazette
FNA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Paragon 28, Inc. Is Fair to Shareholders - Business Wire
Zimmer Biomet to buy Paragon 28 for $1.2B - Mass Device
Paragon 28 stock rating downgraded to Hold at Needham - MSN
Paragon 28 Shares Rise After Zimmer Biomet Buyout Deal - MarketWatch
Zimmer Biomet's rating and oultook affirmed at Moody's as Paragon 28 deal enhances growth and diversifies business - MSN
Latham & Watkins Advises on Zimmer Biomet’s Acquisition of Paragon 28 - lw.com
Zimmer Biomet to Acquire Paragon 28 in $1.2 Billion Deal - GuruFocus.com
Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn - Medical Device Network
Needham & Company LLC Reiterates Hold Rating for Zimmer Biomet (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings (ZBH) Announces Merger Agreement with Par - GuruFocus.com
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details - Yahoo Finance
Zimmer Biomet to Acquire Paragon 28 for $1.2 Billion - TipRanks
Zimmer Biomet acquires Paragon 28 at $13/share By Investing.com - Investing.com UK
Zimmer Biomet set to acquire Paragon 28 for $1.1 billion By Investing.com - Investing.com UK
Zimmer Biomet to acquire Paragon 28 for $13.00 per share in cash upfront - TipRanks
Zimmer Biomet to acquire Paragon 28 for $1.1 bln By Investing.com - Investing.com Australia
Zimmer Biomet to acquire Paragon 28 for $1.1 bln - Investing.com
Zimmer Biomet to buy Paragon 28 for $1.1 billion - Reuters
Zimmer Biomet to buy Paragon 28 for $1.1 billion -January 28, 2025 at 06:11 pm EST - Marketscreener.com
Zimmer Biomet to acquire Paragon 28 for $1.1 billion - PharmaLive
Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28 - PR Newswire
Matrix Asset Advisors Inc. NY Has $9.53 Million Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet Holdings, Inc. entered into a definitive agreement to acquire Paragon 28, Inc. for $1.1 billion - Marketscreener.com
Zimmer Biomet's SWOT analysis: medical device maker's stock faces ERP hurdles - MSN
Merit Financial Group LLC Has $387,000 Stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
Gradient Investments LLC Grows Stock Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Zimmer Biomet : Conformis Settles Patent Dispute With Zimmer Biomet -May 28, 2020 at 08:03 am EDT - Marketscreener.com
Stifel Nicolaus Forecasts Strong Price Appreciation for Zimmer Biomet (NYSE:ZBH) Stock - Defense World
Zimmer Biomet (NYSE:ZBH) Shares Gap Up After Analyst Upgrade - Defense World
Zimmer Biomet (NYSE:ZBH) Shares Gap Up on Analyst Upgrade - MarketBeat
Zimmer Biomet (NYSE:ZBH) Price Target Raised to $138.00 at Stifel Nicolaus - MarketBeat
Stifel raises Zimmer Biomet stock target to $138 on strong outlook - MSN
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) On An Uptrend: Could Fundamentals Be Driving The Stock? - Simply Wall St
SG Americas Securities LLC Sells 109,084 Shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Hip and Knee Reconstructive Market to Reach USD 41,071.4 Million by 2035, Growing at a 5.6% CAGR from 2025 to 2035 | FMI - GlobeNewswire Inc.
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stock - Benzinga
Zacks Research Cuts Earnings Estimates for Zimmer Biomet - Defense World
Stifel raises Zimmer Biomet stock target to $138 on strong outlook By Investing.com - Investing.com South Africa
Zacks Research Forecasts Lower Earnings for Zimmer Biomet - MarketBeat
Roberts Wealth Advisors LLC Makes New $1.95 Million Investment in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - MarketBeat
Assenagon Asset Management S.A. Raises Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World
What to Expect From Zimmer Biomet’s Q4 2024 Earnings Report - MSN
Emerging Market Expansion Supports ZBH Stock Amid Macro Issues - Yahoo Finance
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by Lmcg Investments LLC - MarketBeat
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Acquired by MassMutual Private Wealth & Trust FSB - MarketBeat
Finanzdaten der Zimmer Biomet Holdings Inc-Aktie (ZBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):